Avantor, Inc. (AVTR)

USD 21.11

(-3.96%)

Market Cap (In USD)

14.36 Billion

Revenue (In USD)

6.96 Billion

Net Income (In USD)

321.1 Million

Avg. Volume

8.09 Million

Currency
USD
Country
Basic Materials
Open
-
Prev. Close
-
Day Range
-
Year Range
19.59-28.0
PE
-
EPS
-
Beta Value
1.348
ISIN
US05352A1007
CUSIP
05352A100
CIK
1722482
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Mr. Michael Stubblefield
Employee Count
-
Website
https://www.avantorsciences.com
Ipo Date
2019-05-17
Details
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.